Friday, November 21, 2025

RAMAIAH MEMORIAL HOSPITAL & RAMAIAH MEDICAL COLLEGE HOST GLOBAL WBMT SYMPOSIUM ON CELL THERAPY IN BENGALURU.

Ramaiah Memorial Hospital & Ramaiah Medical College is the epi center of medical innovation today with the inauguration of Worldwide Network for Blood and Marrow Transplantation (WBMT) Symposium on Cell Therapy- Bengaluru 2025.,a landmark global scientific convention focused on the future of cellular therapy(BMT & CART). Leading international experts converged for high impact discussions on CAR-T therapies and Bone Marrow Transplant (BMT)  advancements. This Two day  event was organised by the Ramaiah Bone Marrow  Transplant & Cell Therapy Program- established in 2014 & was inaugurated by Mr.K.B. Sivakumar,IAS,Commissioner of Health & Family Welfare Services,Government of Karnataka . Others who participated are Dr.Nagendra Swamy,-Chief Executive- Ramaiah  Memorial Hospital & Health care Services, & Dr.Damiano Rondelli,(Chicago-USA),President WBMT.  The Symposium is attended by eminent Clinicians,Scientists,researchers and Global experts from USA,Europe,UK,Japan,Brazil,Australia & India to advance dialogue,innovation & collaboration in CAR-T Therapies,Hematopoietic cell transportation and cutting edge cellular therapies. 




WBMT President,Professor Damiano Rondelli said," This symposium is extremely important to the mission of WBMT to promote international collaboration education and increase capacity building in transplantation and cell therapy worldwide. Gathering speakers from this region of the world will impact access & quality of care for many patients in Asia".

Delivering the inaugural address, Dr.Nagendra Swamy, highlighted the institution's commitment to elevate access to advanced cell therapy & strengthening India's position in Global Healthcare innovation.Our priority is to bridge the gap by creating platforms where science,technology professional care and patient needs can align.".

Dr.Santosh k Devadas,HOD & Consultant -Medical Oncology & Chief-BMT at Ramaiah Memorial Hospital said," Cell Therapy with genetically engineered blood cells represents the future of cancer therapy and the cure for genetically inherited diseases such as thalassemia.The conversations at this forum will help us refine pathways and expand the window of oppurtunity for patients'.

Friday, November 14, 2025

CAPILLARY TECHNOLOGIES INDIA LIMITED - IPO OPENS TODAY -FRIDAY NOVEMBER,14,2025.PRICE BAND SET AT Rs.549-577 PER EQUITY SHARE.

 Capillary Technologies India Ltd., -IPO opens on Friday,November,14,2025 and closes on November,18,2025 with price band of Rs.549/- to Rs.577/- per Equity share bearing the face value of Rs.2/- per equity share. Minimum Bid Lot is 25 Equity shares and in multiples of 25 equity shares thereafter.The IPO is fresh issue of  equity shares of face value of Rs.2/- per equity share  aggregating to Rs.3450.00 millions and an offer for sale of 92,28,796 equity shares.The net proceeds from the issue to the extent of upto Rs.1430.00 million will be utilized for funding its cloud infrastructure costs,upto Rs.715.81 million for investment in research,designing and development of company's products & Platform upto Rs.103.42 million for investmnt in purchase of computer systems for it business and the balance for funding inorganic growth through unidentified acquisitions and general corporate purposes .


The Company is a Software  Product Company offering artificial intelligence (AI) based cloud -native Software-as-a- Service (SaaS) products and solutions primarily to enterprise customer globally to develop loyalty of its consumer and channel partners. The Company is among one of  the few  players in the loyalty management space that offer end-to-end loyalty solutions.The Company's consolidated revenue from operations for the six months ended september,30,2025 was Rs. 5982.59 million vis-a-vis Rs.2871.77 million for the six months ended september,30,2024. 

JM Financial Ltd., IIFL Capital Services Ltd., and Nomura Financial Advisory & Securities (P) Ltd.,are the book running lead manager and MUFG Intime India (P) Ltd., is the registrar of the offer.
The shares will be listed in NSE & BSE. For more information Please read the RHP.

Thursday, November 13, 2025

SINGAPORE BUSINESS FEDERATION OPENS FOURTH SINGAPORE ENTERPRISE CENTRE IN BENGALURU TO BOOST SINGAPORE-INDIA BUSINESS COLLABORATION.

The new centre is part of the Global Connect @ SBF initiative by Enterprise Singapore & SBF,which supports Companies in International expansion through advisory,netrworking and business matching.This centre is first outside south east Asia to help Singapore enterprises,especially SME's tap into India's fast growing market.India,the world's fourth largest economy with a projected GDP growth of 6.6% in 2025,remains Singapore's largest source of FDI for the seventh consecutive year.With business interest from Singapore companies rising steadily,the SEC@Bengaluru aims to engage over 470 enterprises in the next two years through trade missions,seminars,and market programmes.

The launch was attended by Ms.Gan Siow Huang,Singapore's Minister of State for Foreign Affairs & Trade and Industry; Ms.Shobha Karandlaje,Union Minster for Labour & Employment & MSME; & Mr.Priyank M Kharge,Karnataka's Minister for Electronics,IT &BT & Rural Development.


A Memorandum Of Understanding (MOU) was signed between LAC Global Pte Ltd., and JVKM India (Mitraa Wellness)to expand collaboration in health & wellness,combining Singapore's science based formulations with India's natural healing traditions.The new SBF_India Business Committee chaired by Mr.Prasoon Mukherjee,Chairman of Universal Success Enterprises Ltd.,will serve as a strategic bridge between the Business Communities of both countries.

"The Opening of SEC@Bengaluru marks a signifiant milestone as we help Singapore enterprises explore India's vibrant market," says Mr.Kok Ping Soon,CEO,SBF. This opens a new Chapter of growth between India & Singapore says Ms.Gan Siow Huang.

About Singapore business Federation (SBF): SBF is Singapore's apex business chamber with over 32,000 members across diverse industries.

Friday, November 7, 2025

THE ALL INDIA AGARBATHI MANUFACTURERS ASSOCIATION (AIAMA) - AIAMA EXPO 2025 INAUGURATED.

India's largest Intrnational conference & exhibition for the agarbathi industry was inaugurated   by  Smt. Shobha Karandlaje, Union Minister of State for Micro,Small and Medium Enterprises at Tripura Vasini,Palace Grounds Bengaluru, yesterday. The three day event starting from yesterday was themed "Traditionally Modern". The minister aloso unveiled the Bureau of Indian Standards (BIS) Certification to establish a new quality benchmark to elevate India's incense manufacturing to Global standards.Speaking at the inauguration,Smt.Shobha Karandlaje,said," The Indian agarbathi industry is the essence of our culture.We aim to create awareness about the agarbathi industry,which has been falsely portrayed harmful,while also calling for research  backed scientific evidence. She also urged the need for using natural flowers for fragrance as our country is the largest producer of flowers.".



The expor brings together industry experts,innovators and thought leaders for curated sessions on fragrance,sustainability & entrepreneurship .The inaugural day featured renowned mythologist Mr.Devdutt Pattanaik,who shared the insights on the symbolism of fragrance in Indian tradition and spirituality.Mr.Ambica Ramanjaneyalu,President,AIAMA,& Managing Director,Ambica group of Companies said," AIAMA Expo 2025,marks a defining moment in our industry's journey.It brings together manufacturers,suppliers and innovators under one roof to celebrate 75 years of legacy while embracing a future driven by quality,sustainability & growth".

Mr.Arjun Ranga,Chairman,AIAMA Expo Committee 2025, & Managing Director,Cycle Pure Agarbathi said," The expo showcased how the agarbathi industry is evolving by combining traditional artistry with modern business practices." spread across 1,20,000 Sq.Ft  will have curated seminars that will cover various aspects of  agarbathi industry including job creation,sourcing of raw materials, research on new fragrances packaging,women empowerment ,export oppurtunities and new age marketing.

Saturday, November 1, 2025

APOLLO CANCER CENTRES TURNS CHOCOLATES INTO HEALTH REMINDERS WITH "CHECK-OLATE"- A SWEET PAUSE THAT COULD SAVE LIFE.

Breast Cancer Awareness Month -Apollo Cancer Centres has launched an unique initiative that blends indulgence with awareness through ' Check-olate' a sweet treat that carries an even sweeter reminder : Take moment for yourself.According to GLOBOCAN,breast cancer remains a leading cause of cancer incidence & mortality among Indian Women,accounting for 13.5% of all new cancer cases and 10.6% of total cancer deaths.Apollo Cancer Centres aims to normalise self-care through Check-Olate & empower women to make breast self-examination a monthly ritual,helping them to take charge of their health early.

Mr. Dinesh Madhavan,President-Group Oncology & International,Apollo Hospital Enterprise Ltd.,said,"When women are healthy,nations prosper.Every woman's well being is a force multiplier that strengthens families,communities and the economy.At Apollo,we see women's health as a National priority& a shared responssibility.The Check-Olate initiative is another purposeful step reminding women that self care is not a privilege; it is power,and it fuels a healthier,stronger,and more prosperous India".


Dr.Jayanthi Thumsi,Lead & Robotic Surgeon,Breast Oncology,Apollo Cancer Centres,Bangalore said," When it comes to breast cancer,early detection isn't just important,it is life saving.Dark Chocolate ,known for its antioxidant and mood enhancing benefits,becomes a comforting messenger of care,reminding every woman that a simple self examination,just a few minutes a month,can make all the difference."
According to NCBI,dark chocolate is rich in antioxidants and flavonoids that help reduce inflammation,support heart health,and uplift mood. 

Ms.Pooja Gandhi, actress, also participated in the event.

Thursday, October 30, 2025

ORKLA INDIA LIMITED -LAUNCHES ITS IPO.

 Orkla India Limited, (Company), Bengaluru based,multi category,Indian Food Company launched its IPO.The IPO opened for subscription on October,29,2025 and will close on October,31,2025.The Company's shares are proposed to be listed on November,6,2025 on the NSE & BSE  Stock Exchanges.ORKLA India IPO is a book build Issue of Rs.1667.54 crores .ORKLA India IPO price band is Rs.695/- to Rs.730/- per share of  Face value of Re.1.The issue includes a reservation of upto 30,000 shares for employees offered at a discount of Rs.69/- to the issue price.



The Company is engaged in the manufacturing & marketing of multi category Indian food like MTR and EASTERN which are known for its authencity and tradition and are deeply rooted in South Indian culinary heritage.The key product categories it offers are spices and  "ready to eat" & "Ready To Cook"categories. The MTR brand was originally established in 1924  & the Company celebrated its centenary last year.ORKLA India's portfolio of products comprises approximately 400 products across all categories.The EASTERN brand was founded in 1983.

ORKLA India is a subsidiary of ORKLA ASA,a Norway listed Company with a legacy spanning over 370 years. ORKLA is head quartered in Norway and its Indian story began in 2007 when it acquired MTR Foods for Rs.353 crores.

For more information,Please read the RHP.


 



Thursday, October 23, 2025

FIRE CRACKER RELATED INJURIES -NARYANA NETHRALYA.

 This year there has been a worrying rise in fire cracker -related injuries,with many children,bystanders and innocent people getting hurt while  celebrating the festival.Narayana Nethralaya has witnessed surge in fire cracker -related eye injuries this Deepavali.In this regard,Dr.Naren Shetty, Director,Narayana Nethralya,shared the demographic data of those affected.Between 19th October and 23rd October, a total of 93 patients with fire cracker -related eye injuries were reported of which adults are ;37, Children (below 18 years); 56,Bystanders:32 & self inflicted injuries: 61. Medical treatment provided :86 & Surgical interventions required : 7.

Types of Injuries: Ranged from mild corneal abrasions to severe cases involving corneal tears,epithelial defects and lens dislocation.By combining caution with festive joy ,we can prevent accidents and protect vision-says Dr.Naren Shetty.

BENGALURU TO HOST "DESIGNUP25"-INDIA'S PREMIER DESIGN CONFERENCE.

 The 9th edition of Design & Innovation Festival comes with a Bold New Theme - "TheDesign Currency".India's leading design & Innovation festival "DesignUp25" will be taking place  from November-3-5,2025 in Bengaluru.DesignUp25 aims to illuminate how design creates economic,social, and environmental value. DesignUp25 is where India's design,tech and innovation communities converge - not just to exchange ideas,but to redefine the very value of design,said Mr.Jay Dutta Founder and Curator,DesignUp & Global head of Design,Deutsche Bank.


The Three day event will bring together global & Indian design leaders through workshops,long talks,lightning sessions and panels that explore how design acts as a powerful medium of exchange -influencing trust,innovation and human experience in an AI-driven world. A major highlight this year will be the Unveiling of the Future Challenge 2025 winners,where youg designers reimagine what "currency could mean in 2050"-from trust and attention to energy & reputation.The challenge was judged by an international jury of design leaders,creative directors and innovation experts,headed by Mr.Thomas Kuber,and Andreas Wegner of Futur 2 Studio,Berlin.

Design is no longer just an aesthetic embellishment -it is currency. Just as currency powers economies,design powers innovation,trust,behaviour and systemic change.There will be galaxy of speakers lined up for the event.

Saturday, October 11, 2025

WINDERGY INDIA 2025 WILL BE HELD IN CHENNAI FROM OCTOBER,29 TO 31 AT CHENNAI TRADE CENTRE-THEME: WIND POWER ;POLICIES & PARTNERSHIPS TOWARDS AATMANIRBHARTA

WINDERGY INDIA 2025,india's only Trade fair & Conference dedicated to the wind energy turn seven this year, as Chennai prepares to host WINDERGY INDIA 2025 FROM oCTOBER,29 TO 31 AT THE Chennai Trade Centre,with more than 30 countries participating & over 15,000 people  expected to attend as visitors. The inaugural session will be graced by Shri.Pralhad Joshi,Union Minister for New & Renewable Energy & Union Minister of State for New & Renewable Energy, Shri. Shripad Yesso Naik.


India ranked Fourth globally in wind energy installations, and the numbers suggest as of August,2025,India's installed wind power capacity is 52681.2 MW,making it one of the largest producers and and advocates for developing wind energy,both indigenously & globally.Moreover, the recent reforms in GST, the Government of India's  initiative to reduce taxes on wind energy equipment from 12% to 5% -is expected to give a much needed boost to the sector and help in achieving the target of 150 GW of wind power capacity.

Friday, September 19, 2025

NETHRADHAMA -SUPER SPECIALITY EYE HOSPITAL IN BENGALURU SUCCESSFULLY PERFORMED CONGENITAL CATARACT SURGERY ON A SIX WEEK OLD INFANT.

The complex procedure was led by world renowned Opthalmologist Prof.Dr. Sri Ganesh,Chairman and Managing Director of Nethradhama, a Super Specialist Eye Hospital in Bengaluru.The patient,a six week old infant was diagnosed with a dense monocular congenital cataract in one eye with a dense fibrous plaque on the posterior capsule of the eye.Commenting on the rarity & complexity of the case, Prof.Dr.Sri Ganesh said," Operating on a six week old infant requires not only surgical expertise but also highly specialised anaesthesia & equipment.Our role does not end with the surgery.There is a need for strict post operative care and parental involvement is crucial for the best possible outcome".

The case presented significant anaesthetic challenges due to the infant's small anatomy & fragility. Dr.Suman Shree R.Director,CEO and HOD-Anaesthesiology at Nethradhama,said," Managing anaesthesia in an infant requires precision at every step-from airway safety to temperature control.This milestone reinforces Nethradhama's commitment to delivering world class outcomes in even the most delicate paediatric cases. It also highlights the depth of our multidisciplinary expertise,where surgical excellence & advanced anaesthesia come together to ensure that infants receive the best possible start to their visual journey".


The parents said," when we saw our baby open the eye and look at us,it was overwhelming.Seeing our child respond after the surgery is a moment we will always remember".

About Nethradhama: Celebrating over 30 years of excellence,Nethradhama boasts of a Centre of Excellence in Jayanagar,Bengaluru.Apart from Jayanagar,they have branches in Rajajinagar, Indiranagar & Whitefield in Bengaluru. Nethradhama also have branches in Mysuru,Davangere & Mangaluru in Karnataka.Nethradhama has the NABH accreditation & also ISO 9001:2015 certification & NABH ECO ( Eye Care Organisation) STANDARDS accreditation. 

Tuesday, September 9, 2025

TVS MOTOR LAUNCHES TVS NTORQ 150; INDIA'S QUICKEST & FIRST HYPER SPORT SCOOTER.

 TVS Motor Company,a global leader in Two and Three wheeler segments,announced the launch of TVS NTORQ 150,India's quickest Hyper Sport Scooter,powered by a 149.7 cc race tuned engine & inspired by stealth aircraft design,the scooter sis a symphony of high performance,sportier aesthetics and cutting edge technology to cater to a new generation of riders,with a special introductory price of Rs.1,19,000/- (Ex showroom,all India). 


Key features of TVS NTORQ are : 

* Segment leading acceleration (0-60 kmph in 6.3 seconds)
* Enhanced safety & Control with ABS,Traction ControlSystem .
* Signature Multi Point Projector head lamps, Stylish front combination lamps & T tail lamps.
* Intuitive ride experience with advanced TFT cluster packed with connected features. 
* Race & street Mode.
* Experience the smart ride with segment -first Alexa & smart watch integration.
* Naked Handlebar. & 4 way navigation switches.
* Vehicle Live tracking.


Addressing the media, Mr.Aniruddha Haldar,Senior Vice President -Head Commuter & EV Business Head Corporate Brand & Media,TVS Motor Company said," Over two millions NTORQians  and 50 self managed ride groups and communities,define the relationship that has been built between One of India's most loved and iconic automotive brands and its riders."

The TVS NTORQ 150 wil be available in Two variants.
* TVS NTORQ 150 -Stealth Silver,Racing Red,Turbo Blue.
* TVS NTORQ 150 with TFT Cluster-Nitro Green,Racing Red,Turbo Blue.

Sunday, August 24, 2025

INDIA ALIGNS WITH SHIFT IN GLOBAL GUIDELINES FOR INFLUENZA VACINATION - TRANSITION IN ACCORDANCE WITH WHO RECOMMENDATIONS

 Zydus Life Sciences Limited,an innovation led global life sciences Company held a health Symposium at Bengaluru to create a convergence of leading health care professionals who spoke on the transition to new influenza vaccination guideline,as recommended by  World Health Organisation (WHO) for northern hemisphere 2025-26.  Global influenza remains a significant public health concern,causing an estimated 4,00,000 respiratory and 3,00,000 deaths across the world annually. In US & Europe almost 50% of the population is vaccinated for seasonal flu annually.India which successfully leads the universal immunization programme(UIP) ,has been able to counter several debilitating childhood vaccine preventable diseases.
From Left to Right : Dr.Jyothi, Dr.Aravind C,Dr.Murali Mohan,Dr.Parvaiz Koul ( International Infectious Disease Expert & Former Advisor,Govt.Of India),Dr.Jagadish Chinnappa,& Dr. Vinay D.

Dr.Sharvil Patel,Managing Director,Zydus Life Sciences Limited said," Good health starts with prevention, and vaccines play a key role in protecting people & improving health.Influenza continues to pose a recurring challenge ,leading to seasonal outbreaks and placing a considerable burden on health care systems.Vaccination plays a vital role in reducing the spread of infection,lowering the severity of disease,& preventing complications,especially among high risk & vulnerable groups."National Centre for Disease Control (NCDC),India has recommended to follow the WHO guidelines to adopt the latest strain of the vaccine,to prevent influenza and influenza-like illnesses which is emerging a serious health concern.The disease disproportionately affects vulnerable populations such as infants,the elderly and individuals with chronic conditions.

In India influenza infections occur seasonaly with twin peaks during the monsoon & winter seasons.This necessitates annual vaccinations of the nationally defined target groups with vaccine composition depending on the current circulating strains. At the moment,administering vaccination for influenza is not  mandatory & the experts recommend that it is advisable that the target groups get vaccinated for influenza every year.